<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent USRE34656 - Use of tetracycline to enhance bone protein synthesis and/or treatment of ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency"><meta name="DC.contributor" content="Lorne M. Golub" scheme="inventor"><meta name="DC.contributor" content="Thomas F. McNamara" scheme="inventor"><meta name="DC.contributor" content="Nungavaram S. Ramamurthy" scheme="inventor"><meta name="DC.contributor" content="The Research Foundation Of State University Of New York" scheme="assignee"><meta name="DC.date" content="1992-5-4" scheme="dateSubmitted"><meta name="DC.description" content="Tetracyclines, antibacterial and non-antibacterial tetracyclines, have been found to be useful in the treatment of osteoporosis in humans by administering to the human suffering from osteoporosis an effective amount of a tetracycline to enhance bone protein synthesis. Tetracyclines which have been found to be effective in the treatment of osteoporosis in humans include minocycline, doxycycline and dedimethylaminotetracyline."><meta name="DC.date" content="1994-7-5" scheme="issued"><meta name="DC.relation" content="GB:787882" scheme="references"><meta name="DC.relation" content="GB:925282" scheme="references"><meta name="DC.relation" content="US:2895880" scheme="references"><meta name="DC.relation" content="US:3304227" scheme="references"><meta name="DC.relation" content="US:3636202" scheme="references"><meta name="DC.relation" content="US:3914299" scheme="references"><meta name="DC.relation" content="US:4248892" scheme="references"><meta name="DC.relation" content="US:4276284" scheme="references"><meta name="DC.relation" content="US:4371465" scheme="references"><meta name="DC.relation" content="US:4454110" scheme="references"><meta name="DC.relation" content="US:4457936" scheme="references"><meta name="DC.relation" content="US:4666897" scheme="references"><meta name="DC.relation" content="US:4704383" scheme="references"><meta name="DC.relation" content="US:4925833" scheme="references"><meta name="DC.relation" content="US:4935411" scheme="references"><meta name="DC.relation" content="US:4935412" scheme="references"><meta name="citation_reference" content="&quot;Anti-Plaque Agents&quot;, Pharmacy Times, 97 (Jul. 1985)."><meta name="citation_reference" content="&quot;British Bio-Technology Group&#39;s Collagenase Inhibitor Adjunctive&quot;, F-D-C Reports, Inc., 13 (1983)."><meta name="citation_reference" content="&quot;Periodontal Disease Research, Guide to Dental Health&quot;, Journal of the American Dental Association, 70-74 (1985)."><meta name="citation_reference" content="&quot;Zyderm Collagen Treatments&quot;, Collagen Corporation, Advertisement, (Dec. 1981)."><meta name="citation_reference" content="Addy, et al., &quot;Comparison of the Immediate Effects on the Subgingival Microflora of Acrylic Strips Containing 40% Chlorhexdine, Metronidazole or Tetracycline&quot;, Journal of Clinical Periodontology, 11:379-386, (1984)."><meta name="citation_reference" content="Addy, et al., &quot;The Development and in Vitro Evaluation of Acrylic Strips and Dialysis Tubing for Local Drug Delivery&quot;, J. Periodonal, 693-699, (Nov. 1982)."><meta name="citation_reference" content="Addy, et al., Comparison of the Immediate Effects on the Subgingival Microflora of Acrylic Strips Containing 40% Chlorhexdine, Metronidazole or Tetracycline , Journal of Clinical Periodontology , 11:379 386, (1984)."><meta name="citation_reference" content="Addy, et al., The Development and in Vitro Evaluation of Acrylic Strips and Dialysis Tubing for Local Drug Delivery , J. Periodonal , 693 699, (Nov. 1982)."><meta name="citation_reference" content="ALZA/P&amp;G Periodontal Disease Partnership:Actisite, F D C Reports , Inc., 8 9 (1990)."><meta name="citation_reference" content="ALZA/P&amp;G Periodontal Disease Partnership:Actisite, F-D-C Reports, Inc., 8-9 (1990)."><meta name="citation_reference" content="Anti Plaque Agents , Pharmacy Times , 97 (Jul. 1985)."><meta name="citation_reference" content="Berman, M. B., &quot;Collagenase and Corneal Ulceration&quot;, 8:141-174, (1980)."><meta name="citation_reference" content="Berman, M. B., Collagenase and Corneal Ulceration , 8:141 174, (1980)."><meta name="citation_reference" content="Bitha, et al., Chemical Abstracts , 72:43253P, (1970)."><meta name="citation_reference" content="Bitha, et al., Chemical Abstracts, 72:43253P, (1970)."><meta name="citation_reference" content="Brandt, et al., Chemical Abstracts , 92:163746m, (1979)."><meta name="citation_reference" content="Brandt, et al., Chemical Abstracts, 92:163746m, (1979)."><meta name="citation_reference" content="British Bio Technology Group s Collagenase Inhibitor Adjunctive , F D C Reports , Inc., 13 (1983)."><meta name="citation_reference" content="Brown et al., &quot;Rheumatoid Artritis in the Gorilla:A Study of Mycoplasma-Host Interaction in Pathogenesis and Treatment&quot;, Comarative Pathology of Zoo Animals, 259-266, (1980)."><meta name="citation_reference" content="Brown et al., Rheumatoid Artritis in the Gorilla:A Study of Mycoplasma Host Interaction in Pathogenesis and Treatment , Comarative Pathology of Zoo Animals , 259 266, (1980)."><meta name="citation_reference" content="Dreisbach, et al., &quot;Induction of Collagenase Production in Vibrio B--30&quot;, J. Bacteriology, vol. 135, No. 2, pp. 521-527, (1978)."><meta name="citation_reference" content="Dreisbach, et al., Induction of Collagenase Production in Vibrio B 30 , J. Bacteriology , vol. 135, No. 2, pp. 521 527, (1978)."><meta name="citation_reference" content="Engesaeter, et al., Chemical Abstracts , 93:142977t, (1980)."><meta name="citation_reference" content="Engesaeter, et al., Chemical Abstracts, 93:142977t, (1980)."><meta name="citation_reference" content="Glantz, et al., Chemical Abstracts , 91:20178w, (1979)."><meta name="citation_reference" content="Glantz, et al., Chemical Abstracts, 91:20178w, (1979)."><meta name="citation_reference" content="Golub, et al., &quot;Minocycline Reduces Gingival Collagenolytic Activity During Diabetes&quot;, Journal of Periodontal Research, 18: 516-526 (1983)."><meta name="citation_reference" content="Golub, et al., &quot;Minocycline Therapy Inhibits the Abnormal Gingival Collagenolytic Activity During Experimental Diabetes&quot;, Journal of Dental Research, 62:290, Abstract 1085, (1983)."><meta name="citation_reference" content="Golub, et al., &quot;Minocycline Therapy Reduces Gingival Collagenolytic Enzyme Activity During Diabetes: A Proposed New Mechanism of Action, J. Of Periodontal Research&quot;, 18: 516-526, Abstract, (1983)."><meta name="citation_reference" content="Golub, et al., Chemical Abstracts , 100:96203a, (1984)."><meta name="citation_reference" content="Golub, et al., Chemical Abstracts, 100:96203a, (1984)."><meta name="citation_reference" content="Golub, et al., Minocycline Reduces Gingival Collagenolytic Activity During Diabetes , Journal of Periodontal Research , 18: 516 526 (1983)."><meta name="citation_reference" content="Golub, et al., Minocycline Therapy Inhibits the Abnormal Gingival Collagenolytic Activity During Experimental Diabetes , Journal of Dental Research , 62:290, Abstract 1085, (1983)."><meta name="citation_reference" content="Golub, et al., Minocycline Therapy Reduces Gingival Collagenolytic Enzyme Activity During Diabetes: A Proposed New Mechanism of Action, J. Of Periodontal Research , 18: 516 526, Abstract, (1983)."><meta name="citation_reference" content="Gomes, et al., &quot;Tetracyclines Inhibit Parathyroid Hormone-Induced Bone Resorption in Organ Culture&quot;, School of Dental Medicine Study, SUNY, (Mar. 19, 1984)."><meta name="citation_reference" content="Gomes, et al., Tetracyclines Inhibit Parathyroid Hormone Induced Bone Resorption in Organ Culture , School of Dental Medicine Study, SUNY, (Mar. 19, 1984)."><meta name="citation_reference" content="Goodman and Gilman, The Pharmacological Basis of Therapeutics , 6th edition, p. 961 2, (1980)."><meta name="citation_reference" content="Goodman and Gilman, The Pharmacological Basis of Therapeutics, 6th edition, p. 961-2, (1980)."><meta name="citation_reference" content="Goodson, et al., &quot;Monolithic Tetracycline-containing Fibers for Controlled Delivery to Periodontal Pockets&quot;, J. Periodontol. 54 575-579 (Jan. 1983)."><meta name="citation_reference" content="Goodson, et al., Monolithic Tetracycline containing Fibers for Controlled Delivery to Periodontal Pockets , J. Periodontol. 54 575 579 (Jan. 1983)."><meta name="citation_reference" content="Katz, S. E., &quot;Is Today&#39;s Meat Fit to Eat?&quot;, Chemical and Engineering News, 80-81 (Mar. 11, 1985)."><meta name="citation_reference" content="Katz, S. E., Is Today s Meat Fit to Eat , Chemical and Engineering News , 80 81 (Mar. 11, 1985)."><meta name="citation_reference" content="Muxfeldt, Chemical Abstracts , 76:140344j, (1972)."><meta name="citation_reference" content="Muxfeldt, Chemical Abstracts, 76:140344j, (1972)."><meta name="citation_reference" content="Myl nikova, Chemical Abstracts , 86:66138h, (1976)."><meta name="citation_reference" content="Myl&#39;nikova, Chemical Abstracts, 86:66138h, (1976)."><meta name="citation_reference" content="O Donovan, J. P., A Chick Screen to Evaluate Chemical Compounds from Janssen Pharmaceutical for Growth Promotion , Chick Growth Promotion Screen Report (1987)."><meta name="citation_reference" content="O&#39;Donovan, J. P., &quot;A Chick Screen to Evaluate Chemical Compounds from Janssen Pharmaceutical for Growth Promotion&quot;, Chick Growth Promotion Screen Report (1987)."><meta name="citation_reference" content="Periodontal Disease Research, Guide to Dental Health , Journal of the American Dental Association , 70 74 (1985)."><meta name="citation_reference" content="Perry, et al., &quot;Systemic Tetracycline in the Treatment of Non-Infected Corneal Ulcers and Persistent Epithelial Defects&quot;, J. Period Res. 83:20, 185-195 (Abstract and Artide) (1984)."><meta name="citation_reference" content="Perry, et al., Systemic Tetracycline in the Treatment of Non Infected Corneal Ulcers and Persistent Epithelial Defects , J. Period Res. 83:20, 185 195 (Abstract and Artide) (1984)."><meta name="citation_reference" content="Plakunov, Chemical Abstracts , 80:104410b, (1973)."><meta name="citation_reference" content="Plakunov, Chemical Abstracts, 80:104410b, (1973)."><meta name="citation_reference" content="Sheridan, P., &quot;Tetracyclines Block Collagenase Activity&quot;, JAMA, 252, 1989-1990 (Oct. 19, 1984)."><meta name="citation_reference" content="Sheridan, P., Tetracyclines Block Collagenase Activity , JAMA , 252, 1989 1990 (Oct. 19, 1984)."><meta name="citation_reference" content="Smirnov, I. V., Chemical Abstracts , 76:30596, (1969)."><meta name="citation_reference" content="Smirnov, I. V., Chemical Abstracts, 76:30596, (1969)."><meta name="citation_reference" content="Valcavi, et al., Chemical Abstracts , 95:6899h, (1981)."><meta name="citation_reference" content="Valcavi, et al., Chemical Abstracts, 95:6899h, (1981)."><meta name="citation_reference" content="Williams et al., &quot;Tetracycline Treatment of Periodontal Disease in the Beagle Dog:&quot;, Journal of Periodontal Research, 16:555-674, (1981)."><meta name="citation_reference" content="Williams et al., Tetracycline Treatment of Periodontal Disease in the Beagle Dog: , Journal of Periodontal Research , 16:555 674, (1981)."><meta name="citation_reference" content="Zyderm Collagen Treatments , Collagen Corporation, Advertisement, (Dec. 1981)."><meta name="citation_patent_number" content="US:RE34656"><meta name="citation_patent_application_number" content="US:07/878,172"><link rel="canonical" href="http://www.google.com/patents/USRE34656"/><meta property="og:url" content="http://www.google.com/patents/USRE34656"/><meta name="title" content="Patent USRE34656 - Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency"/><meta name="description" content="Tetracyclines, antibacterial and non-antibacterial tetracyclines, have been found to be useful in the treatment of osteoporosis in humans by administering to the human suffering from osteoporosis an effective amount of a tetracycline to enhance bone protein synthesis. Tetracyclines which have been found to be effective in the treatment of osteoporosis in humans include minocycline, doxycycline and dedimethylaminotetracyline."/><meta property="og:title" content="Patent USRE34656 - Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("1y3uU_2-MIHksASVqIDADA"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("DEU"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("1y3uU_2-MIHksASVqIDADA"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("DEU"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/usRE34656?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/USRE34656"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=02_RAwABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUSRE34656&amp;usg=AFQjCNFifPrpuNdphW34HEc4lKQHmUf9HQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/USRE34656.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/USRE34656.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/USRE34656" style="display:none"><span itemprop="description">Tetracyclines, antibacterial and non-antibacterial tetracyclines, have been found to be useful in the treatment of osteoporosis in humans by administering to the human suffering from osteoporosis an effective amount of a tetracycline to enhance bone protein synthesis. Tetracyclines which have been found...</span><span itemprop="url">http://www.google.com/patents/USRE34656?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent USRE34656 - Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent USRE34656 - Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency" title="Patent USRE34656 - Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">USRE34656 E</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 07/878,172</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Jul 5, 1994</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">May 4, 1992</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Dec 29, 1983</td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">07878172, </span><span class="patent-bibdata-value">878172, </span><span class="patent-bibdata-value">US RE34656 E, </span><span class="patent-bibdata-value">US RE34656E, </span><span class="patent-bibdata-value">US-E-RE34656, </span><span class="patent-bibdata-value">USRE34656 E, </span><span class="patent-bibdata-value">USRE34656E</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Lorne+M.+Golub%22">Lorne M. Golub</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Thomas+F.+McNamara%22">Thomas F. McNamara</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Nungavaram+S.+Ramamurthy%22">Nungavaram S. Ramamurthy</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22The+Research+Foundation+Of+State+University+Of+New+York%22">The Research Foundation Of State University Of New York</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/USRE34656.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/USRE34656.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/USRE34656.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (16),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (62),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (69),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (5),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (1)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/RE34656&usg=AFQjCNHjxQyfBt7nGwSXXVf2J7-MyGXbJg">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3DRE34656&usg=AFQjCNEv545OXi-jYCnjooL47KFwsIFrSg">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3DRE34656E%26KC%3DE%26FT%3DD&usg=AFQjCNG3y2XMgN7L7lfxBZUNjMR_MwOkLw">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT49936670" lang="EN" load-source="patent-office">Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency</invention-title></span><br><span class="patent-number">US RE34656 E</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37336719" lang="EN" load-source="patent-office"> <div class="abstract">Tetracyclines, antibacterial and non-antibacterial tetracyclines, have been found to be useful in the treatment of osteoporosis in humans by administering to the human suffering from osteoporosis an effective amount of a tetracycline to enhance bone protein synthesis. Tetracyclines which have been found to be effective in the treatment of osteoporosis in humans include minocycline, doxycycline and dedimethylaminotetracyline.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(1)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/USRE34656-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/USRE34656-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(19)</span></span></div><div class="patent-text"><div mxw-id="PCLM4755320" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is:</claim-statement> <div class="claim-dependent"> <div num="1" class="claim">
      <div class="claim-text">1. .[.A.]. .Iadd.The .Iaddend.method of .[.enhancing bone protein synthesis in a human which comprises administering to the human an effective amount of a tetracycline.]..Iadd.claim 20 wherein said disease is osteoporosis .Iaddend..</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is an antibacterial tetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is non-antibacterial tetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is minocycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is doxycycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 7-chlorotetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 5-hydroxytetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 6-demethyl-7-chlorotetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" class="claim">
      <div class="claim-text">9. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 6-demethyl-6-deoxy-5-bydroxy-6-methylenetetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is dedimethylamimotetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" class="claim">
      <div class="claim-text">11. A method in accoredance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 6-alpha-benzylthiomethylenetetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" class="claim">
      <div class="claim-text">12. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is a nitrile analog of tetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" class="claim">
      <div class="claim-text">13. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is a mono-N-alkylated amide of tetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" class="claim">
      <div class="claim-text">14. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 6-fluorodemethyltetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" class="claim">
      <div class="claim-text">15. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 11-alpha-chlorotetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="16" class="claim">
      <div class="claim-text">16. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 2-acetyl-8-hydroxyl-1-tetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" class="claim">
      <div class="claim-text">17. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is 6-demethyl-6-deoxytetracycline.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" class="claim">
      <div class="claim-text">18. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is administered systemically.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" class="claim">
      <div class="claim-text">19. A method in accordance with claim .[.1.]. .Iadd.20 .Iaddend.wherein said tetracycline is administered orally. .Iadd.20. A method of treating mammal with bone deficiency disease by enhancing bone protein synthesis in said mammal which comprises administering to the mammal an effective amount of a tetracycline. .Iaddend.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES66514295" lang="EN" load-source="patent-office" class="description">
    <p>This application is a continuation-in-part application of copending, coassigned patent application Ser. No. 699,048 filed Feb. 7, 1985, now U.S. Pat. No. 4,704,383 which in turn, is a continuation-in-part of copending, coassigned patent application Ser. No. 566,517 filed Dec. 29, 1983, now U.S. Pat. No. 4,666,897.</p>
    <p>The disclosures of the above-identified applications are herein incorporated and made part of this disclosure.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>In pending U.S. patent application Ser. No. 566,517, now U.S. Pat. No. 4,666,897, it is disclosed that tetracyclines, such as the antibiotic tetracyclines, e.g. tetracycline, are useful as anti-collagenolytic agents or as inhibitors of collagenase. These tetracyclines and compositions containing the same are disclosed therein as being useful in the treatment of periodontal diseases, corneal ulcers, rheumatoid arthritis and the like characterized by excessive collagen destruction.</p>
    <p>In pending U.S. patent application Ser. No. 699,048, now U.S. Pat. No. 4,704,383, it is disclosed that the non-antibiotic or non-antibacterial tetracyclines also possess anti-collagenolytic properties and are useful as inhibitors of collagenase. Additionally, these non-antibiotic or non-antibacterial tetracyclines have also been found to be useful in the treatment of periodontal diseases, corneal ulcers, bone deficiency disorders due to excess collagenase production or excessivde collagen destruction, rheeumatoid arthristis and the like. A particularly useful non-antibiotic tetracycline in the practices of this invention is the tetracycline dedimethylaminotetracycline.</p>
    <p>Tetracyclines are useful as broad spectrum antibiotics because they have the ability to inhibit protein synthesis in a wide variety of bacteria. As disclosed in the above-identified pending patent applications, it has also been discovered that tetracyclines, antibiotic tetracyclines and non-antibiotic tetracyclines, have th ability to inhibit collagen-destructive enzymes, such as collagenase, responsiple for the breakdown of connective tissue in a number of diseases, such as periodontal disease, corneal ulcers and rheumatoid arthritis.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>It has been discovered that inhibitors of collagen-destructive enzymes, such as collagenase, are useful in the treatment of mammals, such as humans, to prevent the development of osteoporosis and/or to stimulate bone protein synthesis. In the practices of this invention an effective amount of a physiologically acceptable collagenase inhibitor is systemically administered to the mammal or human to bring about the stimulation of bone protein synthesis or to treat bone deficiency disease or osteoporosis. The amount of the inhibitor administered to the mammal or human can be at a therapeutic level, i.e. substantially the same dosage as would be employed in the treatment of barterial infections and the like, or at a reduced, subtherapeutic level, in the range about 5-60% of the therapeutic dosage. The amount administered in accordance with the practices of this invention would be effective to inhibit the collagen-destructive enzymes, such as collagenase, in the mammal, e.g. subject to which the inhibitor is administered.</p>
    <p>More particularly, it has been discovered that tetracyclines, antibacterial and non-antibacterial tetracyclines, which are inhibitors of collagenase, enhance or stimulate bone protein synthesis and have been found to be useful in the treatment of osteoporosis in humans. In the light of the discovery of this invention that tetracyclines stimulate and enhance bone protein synthesis, tetracyclines have been found to be useful in the treatment of osteoporosis.</p>
    <heading>DETAILED DESCRIPTION OF THE INVENTION</heading> <p>The following disclosures of examples are illustrative of the practices of this invention.</p>
    <heading>EXAMPLE NO. 1</heading> <p>In this experiment 4 groups of adult male rats were set up, viz, a group of normal rats which served as controls, a group of rats that were rendered diabetic by streptozotocin administration and two additional groups of diabetic rats, one of which was administered by oral intubation 20 mg per day of a chemically modified non-antibiotic tetracycline (CMT), and the other of which was orally administered 5 mg per day of minocycline, a semi-synthetic commercially available antibiotic tetracycline. Each of the 4 groups of rats contained 4 rats each. Three weeks after beginning the experiment, but 2 hours before sacrifice, each rat was injected with 1 mCi of H<sup>3</sup> -proline to radioactively label the newly synthesized protein in the skeletal and other tissues. After the rats were killed, the long bones were removed, cleaned free of soft tissue, the mid-shaft of the cleaned bone collected and hydrolyzed in 6N HCI (24 h, 105° C.), and an aliquot measured in a liquid scinitillation spectrometer after evaporating the acid. The data on bone protein synthesis is shown in Table 1.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE I______________________________________The administration of minocycline or chemically-modifiednon-antibiotic tetracycline (CMT) to diabetic rats:effect on bone protein systhesis in vivo          Bone Protein synthesisExperimental Group          (DPM H<sup>3</sup> -Pro/mg bone tissue)______________________________________Controls       886 ± 155Diabetics (D)  588 ± 89D + minocycline          852 ± 145D + CMT        828 ± 248______________________________________</pre>
    
    <p>Inducing diabetes in the rat suppressed protein synthesis in the skeletal tissue; after months of this metabolic dysfunction in the bones, they developed physically and chemically-detectable bone-deficiency disease. When either of the two tetracyclines was orally administered to the diabetics, bone protein synthesis was increased to essentially normal values, and this metabolic alteration was associated with the prevention of the devleopment of osteoporosis.</p>
    <heading>EXAMPLE NO. 2</heading> <p>In this experiment 3 groups of animals were established: a group of non-diabetic controls, a group of untreated diabetics, and a group of diabetic rats that were administered, by the oral route, 1.5 mg doxycycline, an antibiotic tetracycline, per day for the entire 31/2 month experimental period. After 3.5 months, the rats were killed, the bones (femur and tibia) were removed, defleshed, and radiographs taken. Physical and biochemical parameters were also measured. Other bones (mandible) were processed for light microscopy. Diabetes significantly reduced the dry weight, density, ash, matrix, calcium and hydroxyproline content of the skeletal tissue (the unchanged Ca/Hyp ratio indicated the bone was normally calcified even through osteopenic). Long-term doxycycline therapy retarded the loss of organic and inorganic bone constituents in the diabetics even though the severity of hyperglycemia was unaffected. Radiographic changes were consistent with the above findings. In short-term studies, treatment of diabetic rats with a different tetracycline (minocycline) showed a similar pattern of results. Tetracycline therapy in rats retarded osteoporotic changes in bone induced by diabetes.</p>
    <p>It was observed that untreated diabetic rats developed bone deficiency disease, or osteoporosis, based on physical, radiologic, chemical and histologic assessments. However, the tetracycline, doxycycline, therapy prevented the development of diabetes-induced osteoporosis even though the drug had no effect on the severity of the diabetic state, presumably because the drug increased the depressed protein synthesis in the skeletal tissues.</p>
    <heading>EXAMPLE NO. 3</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE II______________________________________Effects of CMT Administration (20 mg per day) on UrinaryCalcium Excretion in Streptozotocum-Diabetic RatsExperimental   Number of Rats                       μg Ca mGroup          per Group    urine per 24 h*______________________________________Control        4             33 ± 5Diabetes       4            691 ± 35Diabetes + CMT 4            398 ± 33______________________________________ Each value represents the mean ± S.E.M. of 12 volumes: a 24 h determination was made for each rat (a = 4 per group), on days 18, 19 and 20 after reducing diabetes</pre>
    
    <p>The results shown above in Table II summarizes the reduction in calcium excretion in the diabetic animals treated with CMT as compared with the untreated diabetic animals. Diabetes dramatically increases the urinary excretion of calcium compared with control values and an elevated urinary excretion of calcium is associated with the development of osteoporosis. Administration of CMT to the diabetic animals reduced the pathologically excessive excretion of calcium by 42%; this is biochemical evidence of the amelioration of the condition resulting from the administration of CMT.</p>
    <heading>EXAMPLE NO. 4</heading> <p>Tetracycline can inhibit tissue degradation by anticollagenase action and has reduced pathological bone resorption through this mechanism (Golub et al. 1983, 84). A study was undertaken to evaluate whether tetracycline could have any discernible effect upon morphologic characteristics of bone undergoing nomral remodeling. Four squirrel monkeys received a daily dose of tetracycline at 100 mg/kg/day given by oral intubation in 3 equal doses. After 17 days of tetracycline administration the animals were sacrificed and the jaws processed for histologic sectioning. Bucco-lingual sections were prepared from bicuspid and cuspid teeth. A defined coronal buccal alveolar bone region was analyzed histologically and histometrically using step-serial sections. Corresponding regions were analyzed from bicuspids and cuspids from 4 animals which had not received tetracycline administration. Morphologic characteristics of the bone were analyzed using a Bioquant computerized digitization system, and comparisons made between the groups. Within the defined region, the total area of alveolar bone and the number of marrow spaces, did not differ between the two groups. However, the area of the narrow spaces was significantly less in tetracycline-receiving animals. The marrow spaces occupied 0.5±0.09(SE)% of the bone in tetracycline-receiving animals, in contrast to the 7.9±1.2(SE)% (t=3.49, p&lt;0.01) present in control animals. In the tetracycline-receiving animals, the marrow spaces appeared to be lined by new bone, as were the periodontal ligament surfaces of the alveolar bone. The increased bone density may have been due to inhibition of resorption without affecting the deposition phase of bone remodeling.</p>
    <p>Although in the practices of this invention many compounds, particularly physiologically acceptable collagenase inhibitors, are useful, it is preferred to employ a tetracycline antibiotic or non-antibiotic. Tetracyclines, broadly, can be characterized as containing four fused carbcyclic groups. This arrangement appears to be characteristic of compounds which are collagenase inhibitors and which are also useful in the practices of this invention. Related compounds, compounds which are related as analogs or homologs of tetracycline, are also useful as well as compounds which are characterized as having three fused carbocyclic groups. Suitable such compounds are disclosed herein and include 7-chlorotetracycline, 5-hydroxytetracycline, 6-demethyl-7-chlorotetracycline, 6-demethyl,-6-deoxy-5-hydroxy-6-methylenetetracycline, 6-alpha-benzylthiomethylenetetracycline, a nitrile analog of tetracycline, a mono-N-alkylated amide of tetracycline, 6-fluorodemethyltetracycline, 11-alpha-chlorotetracycline, 2-acetyl-8-hydroxy-1-tetracycline and 6-demethyl-6-deoxytetracycline.</p>
    <p>As mentioned hereinabove, the compounds employed in the practices of this invention are employed in an effective amount for the treatment of osteoporosis, such as an amount effective to enhance the synthesis of bone protein and/or correct to treat any deficiency disease. The amount employed depends to some extent upon the body weight of the mammal or human being treated. With respect to humans, the amount employed, particularly in the case of compounds which are collagenase inhibitors and/or characterized as being a tetracycline, on a daily dosage, it is usually less than about 400 milligrams and usually below about 200 milligrams. A suitable daily dosage for a human would be in the range 10 milligrams to about 50 milligrams for the treatment of osteoporosis or other bone deficiency disease and for the enhancement of the synthesis of bone protein.</p>
    <p>As will be apparent to those skilled in the art in the light of the foregoing disclosure, many alterations, substitutions and modifications are possible in the practices of this invention without departing from the spirit or scope thereof.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US2895880">US2895880</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 13, 1955</td><td class="patent-data-table-td patent-date-value">Jul 21, 1959</td><td class="patent-data-table-td ">Smith Kline French Lab</td><td class="patent-data-table-td ">Sustained release pharmaceutical product</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3304227">US3304227</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 15, 1965</td><td class="patent-data-table-td patent-date-value">Feb 14, 1967</td><td class="patent-data-table-td ">Loveless Loyal E</td><td class="patent-data-table-td ">Antibiotic-containing animal feed</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3636202">US3636202</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 12, 1968</td><td class="patent-data-table-td patent-date-value">Jan 18, 1972</td><td class="patent-data-table-td ">Lewis A Klein</td><td class="patent-data-table-td ">Treatment of rheumatoid arthritis and related diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3914299">US3914299</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 2, 1973</td><td class="patent-data-table-td patent-date-value">Oct 21, 1975</td><td class="patent-data-table-td ">Research Corp</td><td class="patent-data-table-td ">Tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4248892">US4248892</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 7, 1979</td><td class="patent-data-table-td patent-date-value">Feb 3, 1981</td><td class="patent-data-table-td ">Takeda Chemical Industries, Ltd.</td><td class="patent-data-table-td ">Protocatechuic acid, homoprotocatechuic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4276284">US4276284</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 10, 1975</td><td class="patent-data-table-td patent-date-value">Jun 30, 1981</td><td class="patent-data-table-td ">Brown Stuart I</td><td class="patent-data-table-td ">Corneal and stomach ulcers, rheumatoid arthritis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4371465">US4371465</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 7, 1981</td><td class="patent-data-table-td patent-date-value">Feb 1, 1983</td><td class="patent-data-table-td ">American Home Products Corporation</td><td class="patent-data-table-td ">Mammalian collagenase inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4454110">US4454110</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 1, 1983</td><td class="patent-data-table-td patent-date-value">Jun 12, 1984</td><td class="patent-data-table-td ">Forsyth Dental Infirmary For Children</td><td class="patent-data-table-td ">Self-gelling liquid composition for topical application in the oral cavity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4457936">US4457936</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 7, 1982</td><td class="patent-data-table-td patent-date-value">Jul 3, 1984</td><td class="patent-data-table-td ">Hoechst Aktiengesellschaft</td><td class="patent-data-table-td ">Use of hydroxyphenyl-thiazole-, -thiazoline- and -thiazolidine-carboxylic acids, for influencing the collagen metabolism</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4666897">US4666897</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 29, 1983</td><td class="patent-data-table-td patent-date-value">May 19, 1987</td><td class="patent-data-table-td ">Research Foundation Of State University</td><td class="patent-data-table-td ">Inhibition of mammalian collagenolytic enzymes by tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4704383">US4704383</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 7, 1985</td><td class="patent-data-table-td patent-date-value">Nov 3, 1987</td><td class="patent-data-table-td ">The Research Foundation Of State University Of New York</td><td class="patent-data-table-td ">Antiarthritic</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4925833">US4925833</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 29, 1986</td><td class="patent-data-table-td patent-date-value">May 15, 1990</td><td class="patent-data-table-td ">The Research Foundation Of State University Of New York</td><td class="patent-data-table-td ">Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4935411">US4935411</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 28, 1987</td><td class="patent-data-table-td patent-date-value">Jun 19, 1990</td><td class="patent-data-table-td ">The Research Foundation Of State University Of New York</td><td class="patent-data-table-td ">Collagenase inhibitor, animal feed aditive</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4935412">US4935412</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 13, 1987</td><td class="patent-data-table-td patent-date-value">Jun 19, 1990</td><td class="patent-data-table-td ">The Research Foundation Of State University Of New York</td><td class="patent-data-table-td ">Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=02_RAwABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D787882A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGXDpiUhRjwWpizA3PuAzjNPpnk-Q">GB787882A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=02_RAwABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D925282A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNH6qc-AO2GpWqv8pSuqoXR6w-ZDTQ">GB925282A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="Anti-Plaque+Agents"'>Anti-Plaque Agents</a>", Pharmacy Times, 97 (Jul. 1985).</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="British+Bio-Technology+Group%27s+Collagenase+Inhibitor+Adjunctive"'>British Bio-Technology Group's Collagenase Inhibitor Adjunctive</a>", F-D-C Reports, Inc., 13 (1983).</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="Periodontal+Disease+Research%2C+Guide+to+Dental+Health"'>Periodontal Disease Research, Guide to Dental Health</a>", Journal of the American Dental Association, 70-74 (1985).</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="Zyderm+Collagen+Treatments"'>Zyderm Collagen Treatments</a>", Collagen Corporation, Advertisement, (Dec. 1981).</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Addy, et al., "<a href='http://scholar.google.com/scholar?q="Comparison+of+the+Immediate+Effects+on+the+Subgingival+Microflora+of+Acrylic+Strips+Containing+40%25+Chlorhexdine%2C+Metronidazole+or+Tetracycline"'>Comparison of the Immediate Effects on the Subgingival Microflora of Acrylic Strips Containing 40% Chlorhexdine, Metronidazole or Tetracycline</a>", Journal of Clinical Periodontology, 11:379-386, (1984).</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Addy, et al., "<a href='http://scholar.google.com/scholar?q="The+Development+and+in+Vitro+Evaluation+of+Acrylic+Strips+and+Dialysis+Tubing+for+Local+Drug+Delivery"'>The Development and in Vitro Evaluation of Acrylic Strips and Dialysis Tubing for Local Drug Delivery</a>", J. Periodonal, 693-699, (Nov. 1982).</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Addy, et al., Comparison of the Immediate Effects on the Subgingival Microflora of Acrylic Strips Containing 40% Chlorhexdine, Metronidazole or Tetracycline , Journal of Clinical Periodontology , 11:379 386, (1984).</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Addy, et al., The Development and in Vitro Evaluation of Acrylic Strips and Dialysis Tubing for Local Drug Delivery , J. Periodonal , 693 699, (Nov. 1982).</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">ALZA/P&amp;G Periodontal Disease Partnership:Actisite, F D C Reports , Inc., 8 9 (1990).</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">ALZA/P&amp;G Periodontal Disease Partnership:Actisite, F-D-C Reports, Inc., 8-9 (1990).</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Anti Plaque Agents , Pharmacy Times , 97 (Jul. 1985).</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Berman, M. B., "<a href='http://scholar.google.com/scholar?q="Collagenase+and+Corneal+Ulceration"'>Collagenase and Corneal Ulceration</a>", 8:141-174, (1980).</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Berman, M. B., Collagenase and Corneal Ulceration , 8:141 174, (1980).</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bitha, et al., Chemical Abstracts , 72:43253P, (1970).</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bitha, et al., Chemical Abstracts, 72:43253P, (1970).</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Brandt, et al., Chemical Abstracts , 92:163746m, (1979).</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brandt, et al., Chemical Abstracts, 92:163746m, (1979).</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">British Bio Technology Group s Collagenase Inhibitor Adjunctive , F D C Reports , Inc., 13 (1983).</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brown et al., "<a href='http://scholar.google.com/scholar?q="Rheumatoid+Artritis+in+the+Gorilla%3AA+Study+of+Mycoplasma-Host+Interaction+in+Pathogenesis+and+Treatment"'>Rheumatoid Artritis in the Gorilla:A Study of Mycoplasma-Host Interaction in Pathogenesis and Treatment</a>", Comarative Pathology of Zoo Animals, 259-266, (1980).</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Brown et al., Rheumatoid Artritis in the Gorilla:A Study of Mycoplasma Host Interaction in Pathogenesis and Treatment , Comarative Pathology of Zoo Animals , 259 266, (1980).</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Dreisbach, et al., "<a href='http://scholar.google.com/scholar?q="Induction+of+Collagenase+Production+in+Vibrio+B--30"'>Induction of Collagenase Production in Vibrio B--30</a>", J. Bacteriology, vol. 135, No. 2, pp. 521-527, (1978).</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Dreisbach, et al., Induction of Collagenase Production in Vibrio B 30 , J. Bacteriology , vol. 135, No. 2, pp. 521 527, (1978).</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Engesaeter, et al., Chemical Abstracts , 93:142977t, (1980).</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Engesaeter, et al., Chemical Abstracts, 93:142977t, (1980).</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Glantz, et al., Chemical Abstracts , 91:20178w, (1979).</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Glantz, et al., Chemical Abstracts, 91:20178w, (1979).</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Golub, et al., "<a href='http://scholar.google.com/scholar?q="Minocycline+Reduces+Gingival+Collagenolytic+Activity+During+Diabetes"'>Minocycline Reduces Gingival Collagenolytic Activity During Diabetes</a>", Journal of Periodontal Research, 18: 516-526 (1983).</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Golub, et al., "<a href='http://scholar.google.com/scholar?q="Minocycline+Therapy+Inhibits+the+Abnormal+Gingival+Collagenolytic+Activity+During+Experimental+Diabetes"'>Minocycline Therapy Inhibits the Abnormal Gingival Collagenolytic Activity During Experimental Diabetes</a>", Journal of Dental Research, 62:290, Abstract 1085, (1983).</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Golub, et al., "<a href='http://scholar.google.com/scholar?q="Minocycline+Therapy+Reduces+Gingival+Collagenolytic+Enzyme+Activity+During+Diabetes%3A+A+Proposed+New+Mechanism+of+Action%2C+J.+Of+Periodontal+Research"'>Minocycline Therapy Reduces Gingival Collagenolytic Enzyme Activity During Diabetes: A Proposed New Mechanism of Action, J. Of Periodontal Research</a>", 18: 516-526, Abstract, (1983).</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Golub, et al., Chemical Abstracts , 100:96203a, (1984).</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Golub, et al., Chemical Abstracts, 100:96203a, (1984).</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Golub, et al., Minocycline Reduces Gingival Collagenolytic Activity During Diabetes , Journal of Periodontal Research , 18: 516 526 (1983).</td></tr><tr><td class="patent-data-table-td ">33</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Golub, et al., Minocycline Therapy Inhibits the Abnormal Gingival Collagenolytic Activity During Experimental Diabetes , Journal of Dental Research , 62:290, Abstract 1085, (1983).</td></tr><tr><td class="patent-data-table-td ">34</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Golub, et al., Minocycline Therapy Reduces Gingival Collagenolytic Enzyme Activity During Diabetes: A Proposed New Mechanism of Action, J. Of Periodontal Research , 18: 516 526, Abstract, (1983).</td></tr><tr><td class="patent-data-table-td ">35</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gomes, et al., "<a href='http://scholar.google.com/scholar?q="Tetracyclines+Inhibit+Parathyroid+Hormone-Induced+Bone+Resorption+in+Organ+Culture"'>Tetracyclines Inhibit Parathyroid Hormone-Induced Bone Resorption in Organ Culture</a>", School of Dental Medicine Study, SUNY, (Mar. 19, 1984).</td></tr><tr><td class="patent-data-table-td ">36</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gomes, et al., Tetracyclines Inhibit Parathyroid Hormone Induced Bone Resorption in Organ Culture , School of Dental Medicine Study, SUNY, (Mar. 19, 1984).</td></tr><tr><td class="patent-data-table-td ">37</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Goodman and Gilman, The Pharmacological Basis of Therapeutics , 6th edition, p. 961 2, (1980).</td></tr><tr><td class="patent-data-table-td ">38</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Goodman and Gilman, The Pharmacological Basis of Therapeutics, 6th edition, p. 961-2, (1980).</td></tr><tr><td class="patent-data-table-td ">39</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Goodson, et al., "<a href='http://scholar.google.com/scholar?q="Monolithic+Tetracycline-containing+Fibers+for+Controlled+Delivery+to+Periodontal+Pockets"'>Monolithic Tetracycline-containing Fibers for Controlled Delivery to Periodontal Pockets</a>", J. Periodontol. 54 575-579 (Jan. 1983).</td></tr><tr><td class="patent-data-table-td ">40</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Goodson, et al., Monolithic Tetracycline containing Fibers for Controlled Delivery to Periodontal Pockets , J. Periodontol. 54 575 579 (Jan. 1983).</td></tr><tr><td class="patent-data-table-td ">41</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Katz, S. E., "<a href='http://scholar.google.com/scholar?q="Is+Today%27s+Meat+Fit+to+Eat%3F"'>Is Today's Meat Fit to Eat?</a>", Chemical and Engineering News, 80-81 (Mar. 11, 1985).</td></tr><tr><td class="patent-data-table-td ">42</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Katz, S. E., Is Today s Meat Fit to Eat , Chemical and Engineering News , 80 81 (Mar. 11, 1985).</td></tr><tr><td class="patent-data-table-td ">43</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Muxfeldt, Chemical Abstracts , 76:140344j, (1972).</td></tr><tr><td class="patent-data-table-td ">44</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Muxfeldt, Chemical Abstracts, 76:140344j, (1972).</td></tr><tr><td class="patent-data-table-td ">45</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Myl nikova, Chemical Abstracts , 86:66138h, (1976).</td></tr><tr><td class="patent-data-table-td ">46</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Myl'nikova, Chemical Abstracts, 86:66138h, (1976).</td></tr><tr><td class="patent-data-table-td ">47</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">O Donovan, J. P., A Chick Screen to Evaluate Chemical Compounds from Janssen Pharmaceutical for Growth Promotion , Chick Growth Promotion Screen Report (1987).</td></tr><tr><td class="patent-data-table-td ">48</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">O'Donovan, J. P., "<a href='http://scholar.google.com/scholar?q="A+Chick+Screen+to+Evaluate+Chemical+Compounds+from+Janssen+Pharmaceutical+for+Growth+Promotion"'>A Chick Screen to Evaluate Chemical Compounds from Janssen Pharmaceutical for Growth Promotion</a>", Chick Growth Promotion Screen Report (1987).</td></tr><tr><td class="patent-data-table-td ">49</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Periodontal Disease Research, Guide to Dental Health , Journal of the American Dental Association , 70 74 (1985).</td></tr><tr><td class="patent-data-table-td ">50</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Perry, et al., "<a href='http://scholar.google.com/scholar?q="Systemic+Tetracycline+in+the+Treatment+of+Non-Infected+Corneal+Ulcers+and+Persistent+Epithelial+Defects"'>Systemic Tetracycline in the Treatment of Non-Infected Corneal Ulcers and Persistent Epithelial Defects</a>", J. Period Res. 83:20, 185-195 (Abstract and Artide) (1984).</td></tr><tr><td class="patent-data-table-td ">51</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Perry, et al., Systemic Tetracycline in the Treatment of Non Infected Corneal Ulcers and Persistent Epithelial Defects , J. Period Res. 83:20, 185 195 (Abstract and Artide) (1984).</td></tr><tr><td class="patent-data-table-td ">52</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Plakunov, Chemical Abstracts , 80:104410b, (1973).</td></tr><tr><td class="patent-data-table-td ">53</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Plakunov, Chemical Abstracts, 80:104410b, (1973).</td></tr><tr><td class="patent-data-table-td ">54</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Sheridan, P., "<a href='http://scholar.google.com/scholar?q="Tetracyclines+Block+Collagenase+Activity"'>Tetracyclines Block Collagenase Activity</a>", JAMA, 252, 1989-1990 (Oct. 19, 1984).</td></tr><tr><td class="patent-data-table-td ">55</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Sheridan, P., Tetracyclines Block Collagenase Activity , JAMA , 252, 1989 1990 (Oct. 19, 1984).</td></tr><tr><td class="patent-data-table-td ">56</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Smirnov, I. V., Chemical Abstracts , 76:30596, (1969).</td></tr><tr><td class="patent-data-table-td ">57</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Smirnov, I. V., Chemical Abstracts, 76:30596, (1969).</td></tr><tr><td class="patent-data-table-td ">58</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Valcavi, et al., Chemical Abstracts , 95:6899h, (1981).</td></tr><tr><td class="patent-data-table-td ">59</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Valcavi, et al., Chemical Abstracts, 95:6899h, (1981).</td></tr><tr><td class="patent-data-table-td ">60</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Williams et al., "<a href='http://scholar.google.com/scholar?q="Tetracycline+Treatment+of+Periodontal+Disease+in+the+Beagle+Dog%3A"'>Tetracycline Treatment of Periodontal Disease in the Beagle Dog:</a>", Journal of Periodontal Research, 16:555-674, (1981).</td></tr><tr><td class="patent-data-table-td ">61</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Williams et al., Tetracycline Treatment of Periodontal Disease in the Beagle Dog: , Journal of Periodontal Research , 16:555 674, (1981).</td></tr><tr><td class="patent-data-table-td ">62</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Zyderm Collagen Treatments , Collagen Corporation, Advertisement, (Dec. 1981).</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5773430">US5773430</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 13, 1997</td><td class="patent-data-table-td patent-date-value">Jun 30, 1998</td><td class="patent-data-table-td ">Research Foundation Of State University Of New York</td><td class="patent-data-table-td ">Reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6610274">US6610274</a></td><td class="patent-data-table-td patent-date-value">Dec 18, 2001</td><td class="patent-data-table-td patent-date-value">Aug 26, 2003</td><td class="patent-data-table-td ">Wallace J. Gardner</td><td class="patent-data-table-td ">Anti-inflammatory composition comprising tetracycline</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7214669">US7214669</a></td><td class="patent-data-table-td patent-date-value">Oct 4, 2002</td><td class="patent-data-table-td patent-date-value">May 8, 2007</td><td class="patent-data-table-td ">Tetragenex Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline derivatives and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7749532">US7749532</a></td><td class="patent-data-table-td patent-date-value">Apr 7, 2004</td><td class="patent-data-table-td patent-date-value">Jul 6, 2010</td><td class="patent-data-table-td ">Supernus Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">doxycycline; dosage forms have immediate release and delayed release portions; antiinflammatory, antiarthritic, and antidiabetic agents, periodontal disease, rosacea, acne, dry eyes, hyperparathyroidism</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7786099">US7786099</a></td><td class="patent-data-table-td patent-date-value">Jan 18, 2005</td><td class="patent-data-table-td patent-date-value">Aug 31, 2010</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">such as A-ring aromatized Minocycline, having antibacterial activity; antibiotics</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8206740">US8206740</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 2008</td><td class="patent-data-table-td patent-date-value">Jun 26, 2012</td><td class="patent-data-table-td ">Supernus Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Once daily formulations of tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8318706">US8318706</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td patent-date-value">Nov 27, 2012</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8383610">US8383610</a></td><td class="patent-data-table-td patent-date-value">May 26, 2009</td><td class="patent-data-table-td patent-date-value">Feb 26, 2013</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394405">US8394405</a></td><td class="patent-data-table-td patent-date-value">Dec 17, 2010</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Supernus Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Once daily formulations of tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394406">US8394406</a></td><td class="patent-data-table-td patent-date-value">Dec 17, 2010</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Supernus Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Once daily formulations of tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8470364">US8470364</a></td><td class="patent-data-table-td patent-date-value">Dec 17, 2010</td><td class="patent-data-table-td patent-date-value">Jun 25, 2013</td><td class="patent-data-table-td ">Supernus Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Once daily formulations of tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8513223">US8513223</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td patent-date-value">Aug 20, 2013</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds for treatment of inflammatory skin disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8709478">US8709478</a></td><td class="patent-data-table-td patent-date-value">Jun 18, 2013</td><td class="patent-data-table-td patent-date-value">Apr 29, 2014</td><td class="patent-data-table-td ">Supernus Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Once daily formulations of tetracyclines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2213655A1?cl=en">EP2213655A1</a></td><td class="patent-data-table-td patent-date-value">Apr 28, 2008</td><td class="patent-data-table-td patent-date-value">Aug 4, 2010</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Methods For Purifying Aminoalkyl Tetracycline Compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2269978A2?cl=en">EP2269978A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Jan 5, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2269985A2?cl=en">EP2269985A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Jan 5, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2269991A2?cl=en">EP2269991A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Jan 5, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284150A2?cl=en">EP2284150A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284151A2?cl=en">EP2284151A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284152A2?cl=en">EP2284152A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284153A2?cl=en">EP2284153A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284155A2?cl=en">EP2284155A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284156A2?cl=en">EP2284156A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2284164A2?cl=en">EP2284164A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2287140A2?cl=en">EP2287140A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 23, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2287148A2?cl=en">EP2287148A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 23, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2287150A2?cl=en">EP2287150A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Feb 23, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2292590A2?cl=en">EP2292590A2</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">Mar 9, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Prodrugs of 9-aminomethyl tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2295404A2?cl=en">EP2295404A2</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">Mar 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2295419A2?cl=en">EP2295419A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Mar 16, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2298322A2?cl=en">EP2298322A2</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">Mar 23, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2298323A2?cl=en">EP2298323A2</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">Mar 23, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2301534A1?cl=en">EP2301534A1</a></td><td class="patent-data-table-td patent-date-value">Mar 10, 2003</td><td class="patent-data-table-td patent-date-value">Mar 30, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Amino-methyl substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2301550A1?cl=en">EP2301550A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Mar 30, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline compounds having target therapeutic activities</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2301912A2?cl=en">EP2301912A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Mar 30, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-aminotetracyclines and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2301915A1?cl=en">EP2301915A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Mar 30, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">7-(diethylamino)methyl substituted tetracycline having target therapeutic activities</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2301916A2?cl=en">EP2301916A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Mar 30, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-aminotetracyclines and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2305637A2?cl=en">EP2305637A2</a></td><td class="patent-data-table-td patent-date-value">Oct 25, 2005</td><td class="patent-data-table-td patent-date-value">Apr 6, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311440A1?cl=en">EP2311440A1</a></td><td class="patent-data-table-td patent-date-value">Apr 5, 2002</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Collagenex Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Controlled delivery of tetracycline compounds and tetracycline derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311451A1?cl=en">EP2311451A1</a></td><td class="patent-data-table-td patent-date-value">Mar 10, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Amino-methyl substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311796A1?cl=en">EP2311796A1</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-dedimethylamino tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311797A1?cl=en">EP2311797A1</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-dedimethylamino tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311798A1?cl=en">EP2311798A1</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-dedimethylamino tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311799A1?cl=en">EP2311799A1</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-dedimethylamino tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2316450A1?cl=en">EP2316450A1</a></td><td class="patent-data-table-td patent-date-value">Mar 10, 2003</td><td class="patent-data-table-td patent-date-value">May 4, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Amino-methyl substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2319828A2?cl=en">EP2319828A2</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">May 11, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2319829A1?cl=en">EP2319829A1</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">May 11, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">9-substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2322501A1?cl=en">EP2322501A1</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td patent-date-value">May 18, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">4-dedimethylamino tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2327409A1?cl=en">EP2327409A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 1, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline compound having target therapeutic activities</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2329826A1?cl=en">EP2329826A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 8, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracyclines for the treatment of multiple sclerosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2329828A1?cl=en">EP2329828A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 8, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracyclines for the treatment of ischaemia</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2332546A1?cl=en">EP2332546A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 15, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracyclines for the treatment of stroke</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2332547A1?cl=en">EP2332547A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 15, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracyclines for the treatment of inflammatory bowel disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2332548A1?cl=en">EP2332548A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 15, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracyclines for the treatment of stroke</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2332549A1?cl=en">EP2332549A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 15, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Novel tetracyclines and their use in medicine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2332550A1?cl=en">EP2332550A1</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jun 15, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracyclines for the treatment of neurodegenerative diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2332904A2?cl=en">EP2332904A2</a></td><td class="patent-data-table-td patent-date-value">Jan 18, 2005</td><td class="patent-data-table-td patent-date-value">Jun 15, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Derivatives of tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2345637A2?cl=en">EP2345637A2</a></td><td class="patent-data-table-td patent-date-value">Jul 14, 2003</td><td class="patent-data-table-td patent-date-value">Jul 20, 2011</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">3, 10, and 12a substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2450347A1?cl=en">EP2450347A1</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td patent-date-value">May 9, 2012</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2452935A2?cl=en">EP2452935A2</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td patent-date-value">May 16, 2012</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2455367A1?cl=en">EP2455367A1</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 2007</td><td class="patent-data-table-td patent-date-value">May 23, 2012</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2481723A2?cl=en">EP2481723A2</a></td><td class="patent-data-table-td patent-date-value">Mar 18, 2003</td><td class="patent-data-table-td patent-date-value">Aug 1, 2012</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2682387A2?cl=en">EP2682387A2</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 2009</td><td class="patent-data-table-td patent-date-value">Jan 8, 2014</td><td class="patent-data-table-td ">Tetraphase Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">C7-fluoro substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003005971A2?cl=en">WO2003005971A2</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2002</td><td class="patent-data-table-td patent-date-value">Jan 23, 2003</td><td class="patent-data-table-td ">Paratek Pharm Innc</td><td class="patent-data-table-td ">Tetracycline compounds having target therapeutic activities</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2005009943A2?cl=en">WO2005009943A2</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2004</td><td class="patent-data-table-td patent-date-value">Feb 3, 2005</td><td class="patent-data-table-td ">Paratek Pharm Innc</td><td class="patent-data-table-td ">Substituted tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009143509A1?cl=en">WO2009143509A1</a></td><td class="patent-data-table-td patent-date-value">May 26, 2009</td><td class="patent-data-table-td patent-date-value">Nov 26, 2009</td><td class="patent-data-table-td ">Paratek Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Salts and polymorphs of a tetracycline compound</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010129057A2?cl=en">WO2010129057A2</a></td><td class="patent-data-table-td patent-date-value">May 7, 2010</td><td class="patent-data-table-td patent-date-value">Nov 11, 2010</td><td class="patent-data-table-td ">Tetraphase Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011025982A2?cl=en">WO2011025982A2</a></td><td class="patent-data-table-td patent-date-value">Aug 27, 2010</td><td class="patent-data-table-td patent-date-value">Mar 3, 2011</td><td class="patent-data-table-td ">Tetraphase Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Tetracycline compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011123536A1?cl=en">WO2011123536A1</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 2011</td><td class="patent-data-table-td patent-date-value">Oct 6, 2011</td><td class="patent-data-table-td ">Tetraphase Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Polycyclic tetracycline compounds</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S152000">514/152</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S899000">514/899</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031650000">A61K31/65</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=02_RAwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/65">A61K31/65</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K31/65</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Oct 7, 2003</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20030819</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U0uzlBsVYNr3Md5uzzhbhUouiZaBw\u0026id=02_RAwABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U1oNIvOsq6itBteq0bpUuq_7Bxagw\u0026id=02_RAwABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U3kWF1SD07xzuxN_Tvf5dmRfyuZrQ","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Use_of_tetracycline_to_enhance_bone_prot.pdf?id=02_RAwABERAJ\u0026output=pdf\u0026sig=ACfU3U1YNQeXL2YQwdbyK6pmuFlfdUFcnw"},"sample_url":"http://www.google.com/patents/reader?id=02_RAwABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>